‘Traditional measures of pandemic preparedness don’t explain highest or lowest COVID-19 infections, mortality rates’
Erin Frame from the University of Washington, US, says trust has been shown to be valuable in keeping COVID-19 infection rates relatively …
New report underscores the need for COVID-19 therapeutics
There is a pronounced need for treatments at all stages of COVID-19, a new report has said
Is COVID-19 Wave 3 here? What the ‘R’ value indicates
The last time the ‘R’ value for India had gone over 1 was during February 21-23, 2021
Amid COVID-19 cases, Bihar faces black fungus challenge
Controversy in Bihar as opposition politicians claim state’s declining cases results of antigen tests, not RT-PCR
Bharat Biotech will begin clinical trials of Covaxin on 2-18 age group
The clinical trials will be conducted to evaluate Covaxin’s safety and efficacy on a population group left out of India’s current …
COVID-19 2nd wave: PM Modi, here are 5 things you should do right away
Surveillance and testing, field hospitals, health corps, a human touch and awareness drives can help stem the current wave of COVID-19 in India
‘Double mutant’ COVID-19 variant colonises lungs directly, evades RT-PCR: Experts
The so-called ‘Bengal variant’ of COVID-19 seems to have reached a plateau, say medical experts
The Pandemic Year: Lockdown pushes India’s poverty levels
A five-part series as India marks a year of the dreaded COVID-19 lockdown: We look at how the pandemic became a double burden for the poor in India
The $4 trillion economic cost of not vaccinating the entire world
It is in rich countries’ direct economic interest to ensure poor nations are fully vaccinated as well
Vaccine Watch: European Union gives emergency approval to Moderna COVID-19 vaccine
The vaccine makes use of the mRNA platform like Pfizer’s vaccine, which the EU has already approved for emergency use
The COVID-19 pandemic has already created a disadvantaged generation
Newborns, those about to be born and children under five will be the worst victims in terms of long-term impacts on growth and development
Treatment for COVID-19 in Omicron wave: What to go for, what to avoid
Experimental therapies used to treat COVID-19 in India’s first two waves should not be used this time, warn doctors
COVID-19 common in pets of infected owners: Research
Scientists urge infected pet owners to avoid contact with their pets, so as not to infect them; they could, in turn, become reservoirs of SARS-CoV-2
COVID-19: AIIMS’ serosurvey right in dismissing notion that third wave will affect more children
When Down To Earth compared the AIIMS report to other serosurveys, seroprevalence in children was shown to be rising to 55 per cent, from 5 per …
Building resilience amid COVID-19: Odisha’s tribal youth show the way
Amid COVID-19, 100 young volunteers have been building resilience among tribal communities in five districts of Odisha by promoting public health,…
COVID-19: Lack of shots, digital literacy hindering vaccination in rural UP
The state government has stopped walk-in vaccination, thus making it difficult for 60 million people who are digitally illiterate
COVID-19 vaccines: Waiting for advantage India
Indian firms face the tall order of ramping up production to meet increased demand here and abroad
Kumbh, farmer movement, weddings, polls may have led to spurt in COVID-19 cases: Vardhan
Centre turns down Maharashtra government request of vaccinating individuals above 25 years
The Pfizer vaccine may not be the best choice for frail people, but it’s too early to make firm conclusions
While the deaths of elderly people in Norway are sad, they shouldn’t be cause for alarm. This actually tells us the vaccine is stimulating …
SC Mande: It is too early to say that the UK’s SARS-CoV-2 variant is not in India
India needs more labs dealing with extremely dangerous pathogens as well as trained human resources, says SC Mande, director-general of …
Managing antimicrobial resistance amid COVID-19 is a challenge
Addressing the challenge of excessive use while at the same time assuring sustainable supply of essential antibiotics is key to making health …
COVID-19 vaccines are coming – how will we know they work and are safe?
The results of the Pfizer vaccine trial are highly promising. But the road to eradicating the coronavirus is likely to be long and difficult
Three years into the pandemic, it’s clear COVID won’t fix itself. Here’s what we need to focus on next
Political frankness, avoidance of infections and adoption of new knowledge and technology can be our future respone plan
COVID-19: 6 African countries to receive technology needed to produce mRNA vaccines
South Africa President Cyril Ramaphosa warns that unless Africa has a vaccine market, manufacturing vaccines will soon collapse
New studies explore waning immunity and vaccine efficacy against long COVID
One deals with general efficacy and another is on vaccine effectiveness in preventing or reducing the chances of long COVID